Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Green Plains Inc. Releases Pro Forma Financial Statements

Green Plains Inc. has released its unaudited pro forma consolidated financial statements, presenting the company's financial position and performance as of June 30, 2025, and for the six months ended June 30, 2025, and the year ended December 31, 2024, as if the recent Poet transaction had occurred on those respective dates.

The unaudited pro forma consolidated balance sheet as of June 30, 2025, shows that the company's cash and cash equivalents increased to $108,624, compared to the pro forma adjusted amount of $183,827, following the Poet transaction. Additionally, inventories decreased from $156,411 to $137,685 after the transaction.

In terms of the unaudited pro forma consolidated statement of operations for the year ended December 31, 2024, the revenues decreased from $2,458,796 to $2,227,329 after the Poet transaction. The operating income (loss) also improved from a loss of $47,459 to a gain of $9,102 after the transaction. Furthermore, the net loss attributable to Green Plains decreased from $82,497 to $76,844.

For the six months ended June 30, 2025, the unaudited pro forma consolidated statement of operations reveals a decrease in revenues from $1,154,344 to $1,026,381 following the Poet transaction. The operating loss improved from $90,623 to $3,192 after the transaction. The net loss attributable to Green Plains decreased from $145,144 to $133,351.

These figures illustrate the significant impact of the Poet transaction on Green Plains Inc.'s financial position and performance, with improvements in operating income and reduced net losses for the periods presented. Following these announcements, the company's shares moved 2.62%, and are now trading at a price of $9.02. For the full picture, make sure to review Green Plains's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS